etravirine

cytochrome P450 family 2 subfamily C member 9 ; Homo sapiens







15 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31679131 Clinical Pharmacokinetics and Pharmacodynamics of Etravirine: An Updated Review. 2020 Feb 1
2 27665573 Evaluation of Concomitant Antiretrovirals and CYP2C9/CYP2C19 Polymorphisms on the Pharmacokinetics of Etravirine. 2017 May 3
3 24165884 The effect of single- and multiple-dose etravirine on a drug cocktail of representative cytochrome P450 probes and digoxin in healthy subjects. 2014 Apr 1
4 23111422 Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals. 2013 Jan 2
5 23400742 Pharmacokinetics and short-term safety of etravirine in combination with fluconazole or voriconazole in HIV-negative volunteers. 2013 Jan 1
6 23441978 Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial. 2013 Aug 1
7 22269145 Biotransformation of the antiretroviral drug etravirine: metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolism. 2012 Apr 4
8 22293514 A case of a potential drug interaction between clobazam and etravirine-based antiretroviral therapy. 2012 1
9 21142266 Pharmacokinetic interactions between etravirine and non-antiretroviral drugs. 2011 Jan 1
10 20169036 Profile of etravirine for the treatment of HIV infection. 2010 Feb 2 2
11 20834094 Clinical perspective on antiretroviral drug-drug interactions with the non-nucleoside reverse transcriptase inhibitor etravirine. 2010 1
12 19501215 Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone. 2009 Jul 1
13 19725591 Clinical pharmacokinetics and pharmacodynamics of etravirine. 2009 2
14 20116625 [Etravirine drug interactions]. 2009 Dec 1
15 18662109 Etravirine for the treatment of HIV infection. 2008 Aug 1